Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rap guanine nucleotide exchange factor (GEF) 3 | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | insulin-degrading enzyme | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0442 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.482 | 0.481 |
Echinococcus multilocularis | nardilysin | 0.0029 | 0.0404 | 0.0385 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0442 | 0.5 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0411 | 1 | 1 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0411 | 1 | 0.5 |
Echinococcus granulosus | insulin degrading enzyme | 0.0029 | 0.0404 | 0.0404 |
Schistosoma mansoni | nardilysin (M16 family) | 0.0029 | 0.0404 | 0.0385 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0411 | 1 | 1 |
Giardia lamblia | Rrm3p helicase | 0.0411 | 1 | 0.5 |
Schistosoma mansoni | nardilysin (M16 family) | 0.0029 | 0.0404 | 0.0385 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0411 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.482 | 0.481 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0442 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0411 | 1 | 0.5 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0411 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0442 | 0.004 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0218 | 0.5157 | 0.5 |
Toxoplasma gondii | insulysin, putative | 0.0028 | 0.0369 | 0.8334 |
Schistosoma mansoni | insulysin (M16 family) | 0.0016 | 0.0081 | 0.0061 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0411 | 1 | 1 |
Echinococcus granulosus | 3'partial|nardilysin | 0.0029 | 0.0404 | 0.0404 |
Toxoplasma gondii | rhoptry metalloprotease toxolysin TLN1 | 0.0029 | 0.0404 | 0.9142 |
Schistosoma mansoni | insulysin unit 3 (M16 family) | 0.0029 | 0.0404 | 0.0385 |
Schistosoma mansoni | insulysin unit 3 (M16 family) | 0.0029 | 0.0404 | 0.0385 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.5157 | 1 |
Echinococcus multilocularis | insulin degrading enzyme | 0.0029 | 0.0404 | 0.0385 |
Schistosoma mansoni | hypothetical protein | 0.0411 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0442 | 0.5 |
Echinococcus granulosus | nardilysin | 0.0029 | 0.0404 | 0.0404 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0014 | 0.002 | 0.002 |
Toxoplasma gondii | peptidase M16 inactive domain-containing protein | 0.0018 | 0.0117 | 0.2649 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.482 | 0.481 |
Echinococcus multilocularis | nardilysin | 0.0029 | 0.0404 | 0.0385 |
Toxoplasma gondii | sporozoite developmental protein | 0.0029 | 0.0404 | 0.9142 |
Brugia malayi | hypothetical protein | 0.003 | 0.0442 | 0.0544 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0411 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0442 | 0.004 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0442 | 0.004 |
Brugia malayi | insulin-degrading enzyme | 0.0029 | 0.0404 | 0.0468 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0411 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0442 | 0.008 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0442 | 0.004 |
Echinococcus multilocularis | nardilysin | 0.0018 | 0.0117 | 0.0097 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0411 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.482 | 0.482 |
Chlamydia trachomatis | insulinase family protease III | 0.0029 | 0.0404 | 0.5 |
Brugia malayi | N-terminal motif family protein | 0.0218 | 0.5157 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0411 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 17.571 uM | PUBCHEM_BIOASSAY: Fluorescence polarization-based cell-based high throughput dose response assay to identify activators of insulin-degrading enzyme (IDE). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681] | ChEMBL. | No reference |
EC50 (binding) | > 54.653 uM | PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442] | ChEMBL. | No reference |
EC50 (functional) | > 54.653 uM | PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681] | ChEMBL. | No reference |
IC50 (functional) | = 9.679 uM | PUBCHEM_BIOASSAY: Counterscreen for activators of insulin-degrading enzyme (IDE): fluorescence-based cell-based high throughput dose response LDH release assay to identify compounds that are cytotoxic to HEK cells or compromise cell membrane permeability. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681] | ChEMBL. | No reference |
IC50 (functional) | > 20 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for the identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343, AID493182] | ChEMBL. | No reference |
IC50 (functional) | = 62.5 uM | PUBCHEM_BIOASSAY: Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID489030, AID492945] | ChEMBL. | No reference |
IC50 (functional) | > 100 uM | PUBCHEM_BIOASSAY: Dose Response validation of Inhibitors of Apaf-1 using a Fluorescent Interference Counterscreen assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID489030, AID492945] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.